FDA Approved Promacta for SAA
FDA has designated Promacta as a breakthrough therapy for treating people with SAA. Glaxo Smith Kline has received fast track status in the US for Promacta to treat SAA. I tried to attach a link but was unsuccessful. You can google: GlaxoSmithKline Drug Granted Breakthrough Therapy Designation to read one of several the articles on the topic.
|